Baker Brothers Ups Acadia Pharma Stake

investors continue to reap gains on Monday after Baker Bros

it has increased its stake in the company to 21.8 percent. Baker Bros' Julian Baker and Stephen Biggar also serve on Acadia's Board of Directors. Baker Bros' acquired additional shares in the company through several transactions last week. The highest average buying price per transaction was $28.5484. The investment fund now holds a total of 24.566 million shares. Shares of Acadia surged past the $30 mark and were higher by more than 8 percent at $31.06. The stock has now gained nearly 50 percent over the past five days, but are still lower by around 15 percent since the start of 2016.